FDA issues warning letters to Bausch & Lomb and Indian API maker over GMP lapses

The U.S. Food and Drug Administration sent warning letters to two companies after finding violations of good manufacturing practice.

Bausch & Lomb, which produces ophthalmic products, was cited for lax contamination controls in its facilities.

An Indian active pharmaceutical ingredient manufacturer also received a warning for similar shortcomings, underscoring continued regulatory focus on manufacturing quality.